e-Drug3D

1838

cas 14484-47-0

CLASS

HORMONES
CORTICOSTEROID
TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY (DMD)
PRODRUG
ANTI-INFLAMMATORY
IMMUNOSUPPRESSIVE

ROUTE (list)

ORAL

PK parameters

Tmax 1 HOUR

MW 441.51
NB_atoms 32
XLogP 2.56
PSA 90.647
NB_HD 1
NB_HA 7
fsp3 0.68
Lipinski(0=no;1=yes) 1

FDA
NDA 208684 (label) INN (DEFLAZACORT) EMFLAZA (PTC THERAP) APPROVAL= AP YEAR= 2017
NDA 208685 (label) INN (DEFLAZACORT) EMFLAZA (PTC THERAP) APPROVAL= AP YEAR= 2017 NEWMOLECULARENTITY
NDA 217123 (pdf not found) INN (DEFLAZACORT) DEFLAZACORT (AUROBINDO PHARMA LTD) APPROVAL= AP YEAR= 2024
NDA 217813 (pdf not found) INN (DEFLAZACORT) DEFLAZACORT (TRIS PHARMA INC) APPROVAL= AP YEAR= 2024
NDA 216720 (pdf not found) INN (DEFLAZACORT) DEFLAZACORT (UPSHER SMITH LABS) APPROVAL= AP YEAR= 2024
NDA 216992 (pdf not found) INN (DEFLAZACORT) DEFLAZACORT (UPSHER SMITH LABS) APPROVAL= AP YEAR= 2025
NDA 217741 (pdf not found) INN (DEFLAZACORT) DEFLAZACORT (SUN PHARM) APPROVAL= AP YEAR= 2025
NDA 219254 (pdf not found) INN (DEFLAZACORT) JAYTHARI (ZYDUS LIFESCIENCES) APPROVAL= AP YEAR= 2025
NDA 219417 (pdf not found) INN (DEFLAZACORT) PYQUVI (AUCTA) APPROVAL= AP YEAR= 2025